Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Trial details
- Registry ID
- NCT06072612
- Phase
- Phase 3
Drug identity checked against registry records
Also recorded as Part of the Bria-IMT regimen
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.NCT06072612 | BriaCell Therapeutics Corporation | Phase 3 | Recruiting | 2027-12Estimated |
| No regulatory events match this view.This does not mean no FDA events have occurred. |